Literature DB >> 6360768

Relative roles of insulin clearance and insulin sensitivity in the prebreakfast increase in insulin requirements in insulin-dependent diabetic patients.

D A Skor, N H White, L Thomas, J V Santiago.   

Abstract

During continuous subcutaneous or intravenous insulin infusion therapy, many patients with insulin-dependent diabetes (IDD) require more insulin in the prebreakfast period (0600-0800 h) than earlier in the morning (0100-0300 h). This study was designed to assess whether variations in insulin clearance or insulin sensitivity might contribute to overnight variations in insulin requirements. Euglycemic insulin clamp studies were performed in random sequence from 2400 to 0300 h and from 0500 to 0800 h on successive nights in 10 subjects with IDD. Insulin was infused at a rate of 40 mU/min/m2 and plasma glucose concentration was maintained at 100 mg/dl by a variable rate glucose infusion from a Biostator GCIIS (Miles Laboratories, Elkhart, Indiana). Insulin clearance was (mean +/- SEM) 277 +/- 41 ml/min/m2 between 0700 and 0800 h compared with 256 +/- 41 ml/min/m2 between 0200 and 0300 h (P less than 0.05), while glucose infusion rates were the same [3.86 +/- 0.52 mg/kg/min from 0730 to 0800 h versus 3.99 +/- 0.51 mg/kg/min from 0230 to 0300 h (P = NS)]. All eight patients with a previously documented prebreakfast increase in insulin requirements had higher insulin clearance at this time. These results indicate that differences in insulin clearance between the prebreakfast period and the early morning may account partially for the higher prebreakfast insulin requirements in some subjects with IDD, and the variations in insulin requirements during the night are not due to variations in insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360768     DOI: 10.2337/diab.33.1.60

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Free insulin concentrations in immediately extracted plasma samples and their relationships to clinical and metabolic parameters in insulin-treated diabetic patients.

Authors:  R Giannarelli; P Marchetti; M Giannecchini; G Di Cianni; P Cecchetti; A Masoni; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

2.  Bedtime insulin injections: an alternative regimen.

Authors:  F R Hinde; D I Johnston
Journal:  Arch Dis Child       Date:  1985-04       Impact factor: 3.791

3.  Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1990-01       Impact factor: 10.122

4.  Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.

Authors:  B Beaufrère; M Beylot; C Metz; A Ruitton; R François; J P Riou; R Mornex
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

5.  Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.

Authors:  P De Feo; G Perriello; M M Ventura; F Calcinaro; G Basta; C Lolli; C Cruciani; A Dell'Olio; F Santeusanio; P Brunetti
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

6.  Overnight metabolic profiles in very young insulin-dependent diabetic children.

Authors:  C E de Beaufort; G J Bruining; P D Home; C M Houtzagers; R van Strik
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

7.  Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency.

Authors:  P J Boyle; A Avogaro; L Smith; S D Shah; P E Cryer; J V Santiago
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.